8-K/AThe WireRoutine
Bylaw Amendment
Filed Dec 9, 2025 · 6mo ago · Accession 0001193125-25-312912
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Damora Therapeutics, Inc.
- Ticker
- DMRA
- CIK
- 1800315
- Form type
- 8-K/A
- Filing date
- Dec 9, 2025
- Report date
- Nov 10, 2025
- Document
- glto-20251110.htm
- Size
- 202 KB